DBS's First-Quarter Profit Rose to Record S$2.57 Billion
By Ben Otto
DBS Group Holdings Ltd.'s first-quarter net profit rose 43%, boosted by higher net interest margin.
Net profit for the quarter was record 2.57 billion Singapore dollars (US$1.92 billion), DBS Group, one of Southeast Asia's largest banks by assets, said Tuesday.
Total income rose 34% on year to S$4.94 billion, with net interest margin up 66 basis points. Commercial book net interest income rose to S$3.38 billion from S$2.005 billion a year earlier.
The bank booked record return on equity of 18.6% in the first quarter, up from 13.1% a year ago.
Chief Executive Piyush Gupta said DBS benefitted from "safe-haven deposit inflows during a quarter marked by increased market volatility," adding that business momentum is healthy "with some pockets of moderation."
He expects the bank's overall loans to grow 3%-5% with fee income growth in the high-single digits on recovery in wealth managment and investment banking, as well as card fee growth helped by a recovery in travel. Full-year return on equity will likely be above 17%, he said.
Write to Ben Otto at ben.otto@wsj.com
(END) Dow Jones Newswires
May 01, 2023 20:09 ET (00:09 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track